* PUBLISHED SCIENTIFIC RESULTS FROM PHASE I STUDY SHOW A POTENTIAL SYNERGISTIC EFFECT WITH RITUXIMAB AS VAL001 INCREASES LEVELS OF SURFACE PROTEIN CD20 Source text for Eikon: Further company coverage ...
* The European Medicines Agency's Committee for Orphan Drugs in Europe (the Committee for Orphan Medicinal Products - COMP) has informed Respiratorius of a positive decision regarding Respiratorius ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する